Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Rockwell Medical, Inc.

RMTINASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.01
$0.06(6.04%)
U.S. Market opens in 15h 29m

Rockwell Medical, Inc. (RMTI) Stock Overview

Explore Rockwell Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap36.3M
P/E Ratio-6.34
EPS (TTM)$-0.18
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$0.73
3 Months$0.70
1 Year Target$0.00

RMTI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Rockwell Medical, Inc. (RMTI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.65, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.34 and a market capitalization of 36.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.32%
5-Day Change
-11.45%
1-Month Change
-19.92%
3-Month Change
3.32%
6-Month Change
-19.22%
Year-to-Date (YTD) Change
6.67%
1-Year Change
-47.38%
3-Year Change
-57.56%
5-Year Change
-94.15%
All-Time (Max) Change
-98.37%

Contact Information

248 960 9009
30142 South Wixom road, Wixom, MI, 48393

Company Facts

2,440 Employees
IPO DateJan 27, 1998
CountryUS
Actively Trading

Frequently Asked Questions